scholarly journals Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors

2015 ◽  
Vol 33 (5) ◽  
pp. 1040-1047 ◽  
Author(s):  
Matthew Zibelman ◽  
Yu-Ning Wong ◽  
Karthik Devarajan ◽  
Lois Malizzia ◽  
Alycia Corrigan ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Solid Tumors ◽  
Hdac Inhibitor ◽  
Renal Cell ◽  
Phase I Study ◽  
Mtor Inhibitor ◽  
Advanced Renal Cell Carcinoma

In Vivo and In Vitro Effects of Xenogeneic Immune Ribonucleic Acid in Patients With Advanced Renal Cell Carcinoma: A Phase I Study

1981 ◽  
Vol 126 (1) ◽  
pp. 24-27 ◽  
Author(s):  
Jerome P. Richie ◽  
Bosco S. Wang ◽  
Glenn D. Steele ◽  
Richard E. Wilson ◽  
John A. Mannick
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Ribonucleic Acid ◽  
Renal Cell ◽  
Phase I Study ◽  
Advanced Renal Cell Carcinoma ◽  
In Vitro Effects

Phase I study of temsirolimus (Tem) and pazopanib (Paz) in solid tumors with emphasis on renal cell carcinoma (RCC).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e15113-e15113 ◽  
Author(s):  
T. J. Semrad ◽  
C. Eddings ◽  
M. P. Dutia ◽  
S. Christensen ◽  
D. Lau ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Solid Tumors ◽  
Renal Cell ◽  
Phase I Study

scholarly journals Phase I study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 16020-16020 ◽  
Author(s):  
P. Fischer ◽  
P. Patel ◽  
M. A. Carducci ◽  
D. F. McDermott ◽  
G. R. Hudes ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Study ◽  
Advanced Renal Cell Carcinoma ◽  
Sunitinib Malate

scholarly journals A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma

2014 ◽  
Vol 37 (3) ◽  
pp. 180-186 ◽  
Author(s):  
Paul Monk ◽  
Elaine Lam ◽  
Amir Mortazavi ◽  
Kari Kendra ◽  
Gregory B. Lesinski ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Study ◽  
Interleukin 2 ◽  
High Dose

Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study

2017 ◽  
Vol 85 ◽  
pp. 39-48 ◽  
Author(s):  
Alain Ravaud ◽  
Carlos Gomez-Roca ◽  
Marie-Quitterie Picat ◽  
Laurence Digue ◽  
Christine Chevreau ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Study ◽  
Solid Tumours

scholarly journals Phase I Study of Nivolumab in Combination with Ipilimumab in Metastatic Renal Cell Carcinoma (Mrcc)

2014 ◽  
Vol 25 ◽  
pp. iv361 ◽  
Author(s):  
H. Hammers ◽  
E.R. Plimack ◽  
J.R. Infante ◽  
M. Ernstoff ◽  
B.I. Rini ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Study
Sign in / Sign up

Export Citation Format

Share Document